The physiological function of the adaptor protein TRADD remains unclear because of the unavailability of a TRADD-deficient animal model. By generating TRADD-deficient mice, we found here that TRADD serves an important function in tumor necrosis factor receptor 1 (TNFR1) signaling by orchestrating the formation of TNFR1 signaling complexes. TRADD was essential for TNFR1 signaling in mouse embryonic fibroblasts but was partially dispensable in macrophages; abundant expression of the adaptor RIP in macrophages may have allowed some transmission of TNFR1 signals in the absence of TRADD. Although morphologically normal, TRADD-deficient mice were resistant to toxicity induced by TNF, lipopolysaccharide and polyinosinicpolycytidylic acid. TRADD was also required for TRIF-dependent Toll-like receptor signaling in mouse embryonic fibroblasts but not macrophages. Our findings definitively establish the biological function of TRADD in TNF signaling.
The physiological function of the adaptor protein TRADD remains unclear because of the unavailability of a TRADD-deficient animal model. By generating TRADD-deficient mice, we found here that TRADD serves an important function in tumor necrosis factor receptor 1 (TNFR1) signaling by orchestrating the formation of TNFR1 signaling complexes. TRADD was essential for TNFR1 signaling in mouse embryonic fibroblasts but was partially dispensable in macrophages; abundant expression of the adaptor RIP in macrophages may have allowed some transmission of TNFR1 signals in the absence of TRADD. Although morphologically normal, TRADD-deficient mice were resistant to toxicity induced by TNF, lipopolysaccharide and polyinosinicpolycytidylic acid. TRADD was also required for TRIF-dependent Toll-like receptor signaling in mouse embryonic fibroblasts but not macrophages. Our findings definitively establish the biological function of TRADD in TNF signaling.
The proinflammatory cytokine tumor necrosis factor (TNF; A002291) is a potent inducer of diverse cellular events, including septic shock, the production of other cytokines, cell proliferation and differentiation, necrotic cell death and apoptosis 1, 2 . Most TNF-induced processes are mediated by TNF receptor 1 (TNFR1; A002346), which triggers many signaling pathways, including activation of mitogen-activated protein (MAP) kinases and the transcription factor NF-kB and, in some cases, engagement of the caspase cascade, which leads to apoptosis [3] [4] [5] [6] [7] . NF-kB and MAP kinases are critical in the induction of many cytokines and immunoregulatory proteins and are pivotal for many inflammatory responses 3, 5, 6 . The initiation of these TNFinduced pathways is precisely regulated in physiological conditions, and the aberrant commitment or failure of these pathways may be accountable for the pathology of many human diseases, such as cancer, arthritis and AIDS 2, 8 .
The molecular mechanisms of TNFR1 signaling have been studied intensively. At present, it is believed that the binding of TNF to TNFR1 triggers the formation of trimers of TNFR1 and subsequent formation of the TNFR1 signaling complex [5] [6] [7] . Several proteins, including TRADD (TNFR1-associated death domain protein; A002306), TRAF2 (TNFR-associated factor 2; A002308) and RIP (receptorinteracting protein; A002078), have been found in the TNFR1 signaling complex and are responsible for mediating 'downstream' signaling events such as activation of the NF-kB and Jnk kinase pathways 6, 7, [9] [10] [11] . In some conditions, the TRADD-RIP-TRAF2 complex (complex I) dissociates from TNFR1 and recruits another TNF effector protein, FADD, to form an 'apoptotic complex' (complex II), which activates caspase-8 and the 'downstream' caspase cascade 12 . To better understand the biological functions of the key effectors of TNF signaling, researchers have generated mice deficient in TRAF2, RIP and FADD [13] [14] [15] [16] . Studies of these mice and the cells derived from them have provided many insights into the physiological function of each of these proteins in TNF signaling. First, RIP and TRAF2 are required for TNF-induced activation of the NF-kB and MAP kinase pathways 13, 16, 17 . Second, FADD is essential for TNF-induced apoptosis 14, 15 . Third, RIP is critical for TNF-induced necrotic cell death 18, 19 . In addition, studies suggest that TRAF2 and RIP mediate the recruitment of 'downstream' signaling proteins such as the kinase IKK to the TNFR1 signaling complex to activate specific distal signaling pathways [20] [21] [22] . TRADD and RIP have been found to be necessary for the recruitment and activation of the NADPH oxidase NOX1 to initiate TNF-induced necrotic cell death 23 . However, because of the lack of the TRADD-deficient mice, the physiological function of TRADD in TNF signaling has remained unclear and controversial, although attempts have been made to address this critical issue by overexpression or by 'knocking down' expression of the TRADD protein 9, 24, 25 . For example, it is not known whether TRADD is required for TNF cytotoxicity in vivo and, more notably, it is still unclear which TNF-induced signaling pathways are mediated by TRADD and how TRADD activates such pathways.
In this study, we generated TRADD-deficient (Tradd -/-) mice and found that TRADD has a critical function in TNFR1 signaling by orchestrating the formation of the TNFR1 signaling complex. We also found that TRADD was essential for induction of the four most studied consequences of TNF-induced TNFR1 signaling in mouse embryonic fibroblasts (MEFs): the activation of NF-kB, the activation of MAP kinases, the induction of necrotic cell death and the initiation of apoptosis. Our data show that TRADD was necessary for the recruitment of TRAF2 and optimal recruitment of RIP to the TNFR1 complex, where TRADD was also responsible for RIP ubiquitination, in which TRAF2 and TRAF5 have redundant functions. Unexpectedly, TNFR1 signals, albeit to a lesser degree, were transmitted in Tradd -/-macrophages, perhaps because of the high expression of RIP in this cell type. In addition, TRADD was involved in Toll-like receptor (TLR) signaling dependent on the adaptor TRIF (A004068), also in a cell type-specific way. Collectively, our observations definitively establish the physiological function of TRADD in TNFR1 and TLR signaling.
RESULTS

Generation of
Tradd -/-mice TRADD interacts with RIP through its death domain and with TRAF2 through its amino-terminal region 11 . Therefore, we designed our gene-targeting construct to delete a substantial portion (exons 3-5) of the TRADD protein (amino acids 51-310), including the RIP-and TRAF2-interacting domains ( Supplementary Fig. 1a online) . Southern blot analysis ( Supplementary Fig. 1b ) and PCR (data not shown) identified 14 correctly targeted mouse embryonic stem cell clones. We microinjected two of those into C57BL/6 blastocysts; they were successfully transmitted through the germline. We crossed the genetargeted mice with transgenic mice expressing the Cre recombinase under control of the EIIa adenoviral promoter ('EIIa-Cre') to delete the neomycin-resistance cassette and exons 3-5 of Tradd 26 . We then bred Tradd +/-mice to produce Tradd -/-mice. Successful deletion of Tradd was demonstrated by PCR analysis of DNA obtained from mouse tail tissue ( Supplementary Fig. 1c ) and immunoblot analysis of TRADD in various mouse tissues ( Supplementary Fig. 1d ).
Tradd -/-mice were born at expected mendelian ratios, which indicated no embryonic lethality. The adult null mice seemed normal and behaved and reproduced normally. Examination of the development of lymphoid organs in 6-week-old Tradd -/-mice showed no obvious abnormalities. All secondary lymphoid organs, including Peyer's patches, peripheral lymph nodes, mesenteric lymph nodes and spleen, were present. Quantification of Peyer's patches showed no difference relative to wild-type mice (Supplementary Table 1 online). Histological analysis of spleen showed normal organization of follicles ( Supplementary Fig. 2 online) . We analyzed surface markers on T cell and B cell populations from spleen, lymph nodes and thymus by flow cytometry and found no substantial differences in cell numbers or composition of lymphocyte subsets ( Supplementary  Fig. 3 online) .
Resistance of Tradd -/-mice to TNF toxicity As TRADD is believed to be a critical mediator of TNFR1-mediated TNF signaling and TNF cytotoxicity is mediated by mainly TNFR1 (refs. 6,9), we first assessed whether Tradd -/-mice were sensitive to TNF toxicity. For this, we used a model of TNF-induced hepatitis 27 . We pretreated 7-to 8-week-old Tradd -/-mice, and their wild-type littermates bred from heterozygous mice, with D-galactosamine (GalN), an inhibitor of transcription specifically in the liver 28 , then treated the mice with TNF. Although all wild-type mice died within 6-8 h of treatment with TNF, Tradd -/-littermates were completely protected from TNF-induced liver injury and seemed healthy until we killed them at 24 h after treatment (Fig. 1a) . TdT-mediated dUTP nick end labeling (TUNEL) staining of liver sections from mice killed 6 h after treatment with GalN and TNF showed many apoptotic foci in livers of wild-type but not Tradd -/-mice (Fig. 1b) . Higher circulating concentrations of alanine aminotransferase and aspartate aminotransferase in wild-type mice confirmed the development of liver injury (Fig. 1c) . However, Tradd -/-mice treated with TNF and GalN had concentrations similar to those of untreated controls. Therefore, the deletion of TRADD rendered mice resistant to TNF cytotoxicity.
TRADD is essential for TNFR1 signaling in MEFs TNF can induce many consequences, including the activation of NF-kB and MAP kinases and induction of necrotic cell death and apoptosis [5] [6] [7] 29 . To determine the effects of TRADD deficiency on TNF signaling and to elucidate which consequence were affected by TRADD deletion, we next studied primary MEFs derived from wild-type and Tradd -/-embryos. We genotyped MEFs from each embryo by PCR and confirmed their genotypes by immunoblot analysis with a TRADD-specific antibody (Fig. 2a) . We used wild-type and Tradd -/-MEFs from the same pregnant female for these experiments. To assess activation of the MAP kinase and NF-kB pathways, we examined the phosphorylation of Jnk and degradation of the NF-kB inhibitor IkBa after TNF treatment. TNF induced potent phosphorylation of Jnk and degradation of IkBa in wild-type but not Tradd -/-MEFs (Fig. 2b) .
The concentration of TNFR1 in wild-type and Tradd -/-MEFs was similar (data not shown; discussed below). We further confirmed the failure of TNF to induce NF-kB activation in Tradd -/-MEFs with NF-kB DNA-binding experiments ( Supplementary Fig. 4 online). To ensure that the defect in the activation of these pathways in Tradd -/-MEFs was specific to TNF treatment, we treated these cells with another inflammatory cytokine, interleukin 1b (IL-1b). The extent of IL-1b-induced Jnk phosphorylation and IkBa degradation was similar in wild-type and Tradd -/-MEFs ( Fig. 2c) , and the expression of Jnk and actin was similar (Fig. 2b,c) . Further examination showed that TNF-but not IL-1b-induced activation of the MAP kinases Erk and p38 was also abolished in Tradd -/-MEFs ( Supplementary Fig. 5 online), which suggested that TRADD is required for TNF-induced activation of both NF-kB and MAP kinases. Wild-type MEF cells undergo apoptosis if treated with TNF plus the protein synthesis inhibitor cycloheximide but undergo necrotic cell death when both cycloheximide and z-VAD-fmk, a membrane-permeable 'pan-caspase' inhibitor, are present 29, 30 . To assess the function of TRADD in TNF-induced apoptosis and necrotic cell death, we treated wild-type and Tradd -/-MEFs with cycloheximide alone or with cycloheximide and z-VAD-fmk and then treated them with TNF. As reported before 30 , wild-type MEF cells were sensitive to TNF-induced apoptosis and necrotic cell death. In contrast, we detected neither apoptosis nor necrotic cell death of Tradd -/-MEFs (Fig. 2d) . These results indicated that TRADD was essential for both types of TNFinduced cell death and were consistent with our in vivo toxicity experiments. The resistance of Tradd -/-MEFs to apoptosis was specific to TNF, as apoptosis induced by the cytokine receptor Fas was normal in Tradd -/-MEFs and thymocytes ( Supplementary Fig. 6 online). Therefore, we conclude that TRADD is pivotal for all TNFR1-mediated TNF signaling events examined here in MEFs.
Studies have attempted to address the function of TRADD in TNFR1-mediated TNF signaling 9, 24, 25 . On the basis of results obtained with an overexpression approach, TRADD was thought to recruit RIP and TRAF2 to the TNFR1 signaling complex 9 . Subsequent studies with a small interfering RNA (siRNA) knockdown approach have suggested that TRADD and RIP compete for binding to TNFR1 (refs. 24,25) . To understand the function of TRADD in the formation of the TNFR1 signaling complex, we did immunoprecipitation experiments with a TNFR1-specific antibody in wild-type and Tradd -/-MEFs and then examined the recruitment of RIP and TRAF2 proteins. As reported before 20 , both TRAF2 and RIP precipitated together with TNFR1 after treatment of wild-type MEFs with TNF ( Fig. 3a) . Ub-RIP RIP
TRAF2
Tradd However, in Tradd -/-MEFs, there was much less TNF-induced RIP recruitment and no TRAF2 recruitment, although total input amounts of RIP and TRAF2 were similar for wild-type and Tradd -/-MEFs (Fig. 3a) . As a control, we found that the amount of TNFR1 precipitated with antibody to TNFR1 (anti-TNFR1) was similar in wild-type and Tradd -/-MEFs ( Supplementary Fig. 7 online) . Notably, we found no modified RIP in Tradd -/-MEFs, whereas TNFR1-associated RIP was heavily modified in wild-type MEFs (Fig. 3a) . Published reports have indicated that RIP is modified by ubiquitination in the TNFR1 complex 21, 31 . We confirmed a difference in RIP ubiquitination in TNFR1 immunoprecipitates from wild-type and Tradd -/-MEFs by immunoblot analysis with a ubiquitin-specific antibody ( Supplementary Fig. 8 online) . These results suggest that TRAF2 recruitment is TRADD dependent, that RIP recruitment to TNFR1 does not absolutely require but is enhanced by TRADD and that ubiquitination of RIP requires the presence of TRADD in the TNFR1 complex. The data presented above indicate that TRADD is required for the formation of a functional TNFR1 signaling complex in MEFs. Noncanonical ubiquitination of RIP is critical for relaying a TNF signal to activate IKK 22, 31 . A published report has suggested that TRAF2 is required for noncanonical RIP ubiquitination 31 . As TRAF2 recruitment is TRADD dependent, the absence of TRAF2 in TNFR1 complex may have explained why RIP was not ubiquitinated in Tradd -/-MEFs. To confirm that possibility, we examined RIP recruitment and ubiquitination in Traf2 -/-MEFs. Unexpectedly, we found that RIP was recruited and ubiquitinated normally in Traf2 -/-MEFs (Fig. 3b) . Because TRAF5 has a function redundant with that of TRAF2 in TNF signaling 32 , we then examined TNF-induced recruitment and ubiquitination of RIP in Traf5 -/-MEFs and Traf2 -/-Traf5 -/-(double-knockout) MEFs. Whereas TNF-induced RIP recruitment was normal in both Traf5 -/-MEFs and Traf2 -/-Traf5 -/-MEFs, we detected TNF-induced RIP ubiquitination in Traf5 -/-MEFs but not in the Traf2 -/-Traf5 -/-MEFs (Fig. 3b) . TRAF2 was recruited to the TNFR1 complex similarly in Traf5 -/-MEFs and wild-type cells (Fig. 3b) . We confirmed expression of TRAF2 and TRAF5 in these cells by immunoblot analysis (Fig. 3c) . These results suggest that TRAF2 and TRAF5 have a redundant function in mediating TNFinduced RIP ubiquitination.
Modest TNF signaling in Tradd -/-macrophages To investigate whether TRADD is essential for TNFR1 signaling in cells other than MEFs, we treated peritoneal macrophages isolated from wild-type and Tradd -/-mice with TNF. Unexpectedly, unlike in MEFs in which we noted no signaling, we detected Jnk phosphorylation and IkBa degradation in Tradd -/-macrophages, although less so than in wild-type cells (Fig. 4a) . To ensure that the TNF-induced activation of NF-kB and Jnk in Tradd -/-macrophages was mediated by TNFR1 and not TNFR2, we treated macrophages with human TNF, which binds only to TNFR1. Again, we noted small amounts of Jnk phosphorylation, IkBa degradation and p38 phosphorylation in Tradd -/-macrophages (Fig. 4b) , which suggested that TNF induced activation of NF-kB and MAP kinases in Tradd -/-macrophages mainly through TNFR1. This observation indicates that deletion of TRADD has a different effect on TNFR1 signaling in MEFs than in macrophages.
To extend those findings, we assessed the recruitment of RIP and TRAF2 by TNFR1 in Tradd -/-macrophages (as described in Fig. 3) . After TNF treatment, slightly less RIP was recruited to the TNFR1 signaling complex in Tradd -/-than in wild-type macrophages, but RIP recruitment was much more efficient than that in Tradd -/-MEFs (Fig. 4c) . However, RIP was ubiquitinated much less efficiently in Tradd -/-macrophages than in wild-type cells (Fig. 4c) . Notably, a small amount of TRAF2 was recruited to TNFR1 after treatment of Tradd -/-macrophages with TNF (Fig. 4c) ; this finding further confirmed the different requirement for TRADD in TNFR1 signaling in MEFs and macrophages. Consistent with that conclusion, TNF induced the death of Tradd -/-macrophages (Fig. 4d) but not Tradd -/-MEFs (Fig. 2d) .
To explore the potential mechanism underlying the apparent tissue specificity of TNFR1 signaling, we examined the expression of RIP and TNFR1 in macrophages and MEFs. Although we detected similar amounts of TNFR1 in these cells, there was much more RIP in macrophages than in MEFs (Fig. 4e) . As RIP can interact with TRAF2 (ref. 11), our data suggest that in the absence of TRADD, the abundant RIP in macrophages may be sufficient to recruit TRAF2 and to form a functional TNFR1 signaling complex in response to TNF, albeit less efficiently than in wild-type cells. 
TRADD in TRIF-dependent TLR signaling
Published studies have suggested that toxicity resulting from lipopolysaccharide (LPS; TLR4 ligand) and polyinosinic-polycytidylic acid (poly(I:C); TLR3 ligand) in the presence of GalN is TNFR1 dependent 33, 34 . Therefore, we tested whether Tradd -/-mice are resistant to LPS and poly(I:C) toxicity by studying 7-to 8-week-old wild-type and Tradd -/-littermates born from interbred Tradd +/-mice. Treatment with LPS plus GalN resulted in 100% mortality of wild-type mice within 9-10 h, but Tradd -/-littermates remained unaffected until we killed them after 24 h (Fig. 5a) . TUNEL staining of liver sections showed massive apoptosis of hepatocytes of wild-type mice but not those of Tradd -/-mice (data not shown). Higher concentrations of serum alanine aminotransferase and aspartate aminotransferase in wild-type mice confirmed the presence of liver damage (Supplementary Fig. 9 online) . High doses of LPS alone (1 mg per mouse) were lethal to both wild-type and Tradd -/-mice (data not shown).
To determine whether the resistance of Tradd -/-mice to treatment with GalN plus LPS was the result of a defect in LPS signaling or TNFR1 signaling, we examined LPS signaling in peritoneal macrophages isolated from 7-week-old wild-type and Tradd -/-littermates. Wild-type and Tradd -/-macrophages had similar amounts of LPSinduced phosphorylation of Jnk and p38 and degradation of IkBa (Fig. 5b) . Similarly, Tradd -/-mice were also resistant to toxicity induced by treatment with poly(I:C) plus GalN; Tradd -/-mice were healthy until we killed them at 72 h after treatment, whereas their wild-type littermates were dead within 30 h of treatment (Fig. 5c) . Nevertheless, we noted no difference in poly(I:C)-induced phosphorylation of Jnk and p38 and degradation of IkBa in wild-type versus Tradd -/-macrophages (Fig. 5d) . These results indicate that deletion of TRADD does not disrupt TLR3 and TLR4 signaling in macrophages. Therefore, the resistance of Tradd -/-mice to treatment with LPS and poly(I:C) in the presence of GalN was most likely due to a defect in TNFR1 signaling.
In addition, we also measured the LPS-and poly(I:C)-induced production of various inflammatory cytokines in Tradd -/-mice (in vivo) and macrophages (in vitro). Tradd -/-mice showed no difference relative to wild-type mice in TNF production after treatment with LPS plus GalN or treatment with poly(I:C) plus GalN but had slightly less production of IL-6 induced by LPS or poly(I:C) (Fig. 5e,f) . Although Tradd -/-macrophages produced similar amounts of TNF, IL-6 and IL-12 in response to LPS, the production of all these three cytokines in response to poly(I:C) treatment was notably lower in these cells than in wild-type macrophages (Fig. 5g) . However, poly(I:C)-induced production of interferon-b was not altered in Tradd -/-macrophages ( Supplementary Fig. 10 online) . These data suggest that deletion of TRADD did not affect TLR4 and TLR3 signaling but may have had some effect on the production of some cytokines. This may have been due in part to a secondary effect of the defect of TNFR1 signaling, as the cytokines were measured at different times after treatment.
As TRADD deletion had different effects on TNF signaling in MEFs and macrophages, we next tested whether TLR4 and TLR3 signaling were altered in Tradd -/-MEFs. Because of the weaker activation of NF-kB by LPS and poly(I:C) in primary MEFs, we examined IkBa phosphorylation instead of its degradation. Whereas LPS-induced phosphorylation of Jnk and IkBa was normal in Tradd -/-MEFs (Fig. 6a) , poly(I:C)-induced phosphorylation of IkBa and Jnk was impaired in these cells (Fig. 6b) . Poly(I:C)-induced signaling was normal in TNFR1-deficient MEFs (Fig. 6c) , which indicates direct involvement of TRADD in TLR3 signaling.
It is known that LPS-induced NF-kB activation can be mediated by two redundant pathways: the TRIF pathway (which is in part RIP dependent) and the adaptor protein MyD88-dependent pathway 35, 36 . In contrast, TLR3 signals exclusively through the TRIF pathway 36 . Therefore, the unaffected TLR4 signaling in Tradd -/-MEFs may have been due to the presence of an intact MyD88-dependent pathway. To test that possibility, we transfected Tradd -/-MEFs with an siRNA construct specific for MyD88 and then treated them with LPS. Phosphorylation of both IkBa and Jnk was lower in Tradd -/-MEFs transfected with the MyD88-specific siRNA than in those transfected with control siRNA (Fig. 6d) . The residual phosphorylation of Jnk and IkBa was probably due to incomplete knockdown of MyD88. In contrast, LPS-induced phosphorylation of Jnk and IkBa was not affected in wild-type MEFs transfected with the MyD88-specific siRNA, presumably because of the presence of an intact TRIFdependent pathway (Fig. 6d) . We also analyzed cytokine production in response to LPS and poly(I:C) in MEFs. TRADD deficiency did not affect the production of TNF and IL-6 in LPS-treated cells, but poly(I:C)-induced production of these cytokines was notably lower in Tradd -/-cells (Fig. 6e) . Thus, TRADD seems to be involved in TLR3-and TLR4-mediated MyD88-independent activation of NF-kB and MAP kinases in MEFs.
DISCUSSION TNF signaling has been one of the most intensively studied research fields for almost two decades. In particular, a wealth of literature on TNFR1 signaling has been generated because TNFR1 mediates most of the TNF-induced diverse cellular responses. Understanding of the molecular mechanisms of TNFR1-mediated TNF signaling has been greatly advanced by studies of mice lacking TNFR1 effector proteins such as TRAF2, RIP and FADD [13] [14] [15] [16] . However, even though TRADD was identified as a component of the TNFR1 complex in 1995, the physiological function of TRADD in TNF signaling has remained vague and debatable because of the unavailability of a TRADDdeficient animal model. In this report, we have used Tradd -/-mice to show that TRADD serves an important function in TNFR1 signaling by mediating the formation of TNFR1 signaling complexes. Our study has indicated that the essential function of TRADD in TNFR1 signaling is tissue specific, as deletion of TRADD resulted in the complete failure of all TNF-mediated signaling events in MEFs but only partial impairment in macrophages. We conclude that the presence of abundant RIP in macrophages may be sufficient to overcome the absence of TRADD and allow transmission of TNF signals to some extent.
It has been speculated that deletion of TRADD in the mouse may lead to early embryonic death. To avoid that potential obstacle and to ensure that TRADD-deficient cells would be available for us to study the function of TRADD in TNFR1 signaling, we initially generated mice with conditional knockout of TRADD. However, unexpectedly, we found that Tradd -/-mice were viable and developmentally normal.
The existing literature on the function of TRADD in TNFR1-mediated signaling is confusing and controversial. Early studies suggested that TRADD mediates the activation of NF-kB and the induction of apoptosis by recruiting 'downstream' effector proteins such as TRAF2, RIP and FADD [9] [10] [11] . Subsequent reports of siRNA-mediated knockdown of TRADD expression have indicated that TRADD is dispensable for TNF-induced apoptosis 24 and necrotic cell death 25 and that RIP recruitment and ubiquitination is enhanced when TRADD expression is lower 25 . In our study here of Tradd -/-mice, MEFs and macrophages, we found that TRADD was essential for TNF cytotoxicity in vivo and for all known TNFR1-mediated consequences in MEFs but was less critical in the transduction of TNFR1 signals in macrophages. On the basis of our results, it was apparent that TRADD promoted the recruitment of RIP and TRAF2 to the TNFR1 complex even though RIP could interact directly with TNFR1 in its absence. That finding is probably explained by the higher binding affinity of TRADD for TNFR1, relative to that of RIP for TNFR1 (refs. 9,11) . Therefore, in many types of cells in which RIP abundance is relatively low, such as MEFs, TRADD is necessary for adequate recruitment of RIP and its ubiquitination by TRAF2 or TRAF5. More notably, without TRADD, the 'trivial' amount of RIP recruited to TNFR1 in these types of cells is not sufficient to transduce any TNFR1 signals. In these types of cells, TRADD seems necessary for the recruitment of other effectors, such as TRAF2 and FADD, to the signaling complexes. That conclusion is consistent with published findings that FADD, which is recruited by TRADD, is required for TNF-induced apoptosis 14, 15 and that TRADD is needed for TNF-induced, NADPH oxidase NOX1-mediated necrotic cell death 23 .
In contrast, in cells in which RIP abundance is high, such as macrophages, TRADD is less critical for RIP recruitment to TNFR1. The presence of large amounts of RIP in these cells may be a factor in allowing RIP to be recruited to TNFR1 and, because RIP interacts directly with TRAF2 and FADD 11, 21 , to recruit other effector proteins to TNFR1 in the absence of TRADD. Nevertheless, abundant RIP cannot completely overcome TRADD deficiency, as TNFR1 signaling was much weaker in Tradd -/-macrophages than in wild-type macrophages. It has been suggested that TRADD is involved in signaling pathways beyond TNFR1 signaling. For example, it has been reported that nuclear TRADD forms a complex with transcription factor STAT1-a and affects interferon-g signaling 37 . We found that Tradd -/-mice were resistant to toxicity resulting from LPS and poly(I:C), but this resistance probably resulted from a defect in TNFR1 signaling, as TRADD deletion did not affect TLR4 and TLR3 signaling in macrophages. However, we did find that deletion of TRADD impaired TLR3 signaling and the TRIF-dependent arm of TLR4 signaling in MEFs. The different effects of TRADD deletion on TLR signaling in macrophages and MEFs may have been due to the different amounts of RIP in these cells, as RIP is required for TRIF-dependent TLR3 and TLR4 signaling 38, 39 . In MEFs, TRADD may be required for the ubiquitination of RIP in response to treatment with poly(I:C) or LPS.
TRADD has also been found to be a component of RIG-like helicase antiviral pathway 40 . Obviously, TRADD has a much broader function in mediating various biological processes than simply serving as an effector protein of TNFR1. The availability of Tradd -/-mice will provide a better understanding of the physiological functions of TRADD.
METHODS
Animals. C57BL/6 mice were from the National Cancer Institute. B6.FVBTg(EIIa-Cre)C5379Lmgd/J-transgenic mice and TNFR1-KO mice were from The Jackson Laboratory. All animal experiments followed protocols approved by the US National Cancer Institute Animal Care and Use Committee and guidelines of the US National Institutes of Health.
Generation of Tradd -/-mice. The pKO Scrambler 917 TK vector was used to construct the targeting vector. Tradd was amplified from a bacterial artificial chromosome clone isolated from 129/Sv RPC122 mouse bacterial artificial chromosome DNA library in three fragments: a 3.5-kilobase first fragment (HpaI-HindIII), a 2.2-kilobase second fragment (SacII-XmaI) and a 6.7-kilobase third fragment (SrfI-NotI). A neomycin-resistance cassette flanked by Frt and loxP sites was excised from pLTM260 vector with HindIII and SacII and was cloned between the first and the second fragments. A third loxP site was inserted after the exon 5 of Tradd between the second and the third fragments. The targeting vector was made linear with PvuI and was transfected by electroporation into the CMT-1 mouse embryonic stem cell line derived from the 129/S6SvEv mouse strain according to a standard procedure. Embryonic stem clones resistant to the aminoglycoside G418 and ganciclovir (192 clones) were picked and were screened for the gene-targeting event. Presence of the 3¢ homologous recombination was assessed by Southern blot analysis with a DNA probe just outside the targeting construct. Presence of the 5¢ homologous recombination event was assessed by PCR with the primers 5RecF (5¢-CACTCGGTTTGGAAACGAAT-3¢) and 5RecR (5¢-CTACCCGGTA GAATTCATA-3¢). The 55 positive embryonic stem clones were further checked for presence of the third loxP site (after exon 5) by PCR with the primers loxPF (5¢-TTTCAGCCAGGTGGTGGTGCACGC-3¢) and loxPR (5¢-GCAATCCTCC TGCCTCAACATCCT-3¢). Of the 14 positive clones, 2 independent embryonic stem clones were microinjected into blastosysts from C57BL/6 mice to generate chimeras. Male chimeric mice were bred to C57BL/6 female mice for germline transmission of the targeted gene. Gene-targeted mice were crossed with EIIaCre-transgenic mice for deletion of the neomycin-resistance cassette and a portion of Tradd. Successful gene deletion was confirmed by PCR with the primers deltaF (pr1; 5¢-TGCACATGTGTCCTCGAGTG-3¢) and deltaR (pr2; 5¢-GGAGAGCTTGGCTGTCTTGG-3¢).
Southern blot analysis. Embryonic stem cell genomic DNA was digested with HindIII, was separated by agarose gel electrophoresis and was transferred to nitrocellulose membranes. ULTRAHyb solution (Ambion) with a 32 P-labeled probe (Strip-EZ DNA kit; Ambion) was used for hybridization.
Reagents. Antibody to phosphorylated Jnk (44-682G) was from Biosource; anti-MyD88 (F-19), anti-IkBa (C-21), anti-TRADD (H-278), anti-TRAF5 (E-4) and anti-TRAF2 (N-19) were from Santa Cruz Biotechnology; anti-Jnk (G151-666) and anti-RIP (G322-2) were from Pharmingen; anti-actin (AC-40) was from Sigma; anti-TNFRI (AF-425-PB) and anti-TRAF2 (324522) were from R&D Systems; and antibody to phosphorylated Erk (9101), p38 (3D7; 28B10) and IkBa (14D4), and anti-Erk (9106) and anti-p38 (9212) were from Cell Signaling. GalN, LPS and poly(I:C) were from Sigma. Mouse TNF was from Biosource; human TNF and IL-1b were from R&D Systems; and z-VAD-fmk (benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone) was from MP Biomedicals.
In vivo toxicity assays. These experiments were in accordance with Animal Care and Use Committee guidelines. Tradd -/-and wild-type siblings 7-8 weeks of age were sensitized by intraperitoneal administration of 700 mg GalN per kg body weight (700 mg/kg). After 15 min of GalN treatment, a sublethal dose of recombinant mouse TNF diluted with pyrogen-free saline (20 mg/kg) or a lethal dose of LPS (100 mg/kg) or poly(I:C) (50 mg/kg) was administered intravenously (TNF) or intraperitoneally (LPS and poly(I:C)). Blood was collected from the tail vein. Serum was separated and was analyzed for transaminases on a Vitros 250 chemistry analyzer.
TUNEL assay. At 6 h after treatment, mouse livers were excised, were fixed in 10% (vol/vol) buffered formalin, were cut into sections 5 mm in thickness and were analyzed by TUNEL assay according to manufacturer's protocol (In Situ Cell Death Detection kit; Roche).
Preparation of MEFs. MEFs were prepared according to a published protocol 41 with some modifications. Embyros at day 13.5 of gestation were isolated from pregnant mice. Each embryo was incubated for 30 min at 37 1C in a separate Eppendorf tube in Cellstripper solution (Cellgro). Afterward, cells were 'mashed' by being pipetted, then were filtered through cell strainers and were cultured in DMEM with 10% (vol/vol) FBS.
Preparation of peritoneal macrophages. Mice were injected intraperitoneally with 1.5 ml of 3% (wt/vol) thioglycolate (BD Bioscience). Peritoneal exudates were isolated 3 d after injection by lavage of the peritoneal cavity with 10 ml ice-cold Hank's balanced-salt solution. Cells were then plated in cell culture plates, were washed twice with Hank's balanced-salt solution 2 h after plating and were incubated overnight in DMEM with 10% (vol/vol) FBS before experiments. For immunoprecipitation, macrophages from three mice of each group, wild-type or Tradd -/-, were pooled together.
Immunoblot analysis and coimmunoprecipitation. After treatment, cells were collected and lysed in M2 buffer (20 mM Tris, pH 7, 0.5% (vol/vol) Nonidet-P40, 25 mM NaCl, 3 mM EDTA, 3 mM EGTA, 2 mM dithiothreitol, 0.5 mM phenylmethyl sulfonyl fluoride, 20 mM b-glycerol phosphate, 1 mM sodium vanadate and 1 mg/ml of leupeptin). Cell lysates were separated by SDS-PAGE and analyzed by immunoblot. Proteins were visualized by enhanced chemiluminescence according to the manufacturer's instructions (Amersham). For immunoprecipitation, cells were treated with mouse TNF (30 ng/ml) and then were collected in M2 buffer. Lysates were mixed and were precipitated with anti-TNFR1 (AF-425-PB; R&D Systems) and protein G-agarose beads by overnight incubation at 4 1C. Beads were washed five times with lysis buffer and bound proteins were separated by 4-20% SDS-PAGE and detected by immunoblot analysis.
Cytotoxicity assay. TNF-induced cell death was assessed with the tetrazolium dye colorimetric test. The absorbance of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) was then measured with a plate reader at 570 nm.
Enzyme-linked immunosorbent assay (ELISA). The production of TNF, IL-6 and IL-12 was measured by ELISA according to the instructions of the kit manufacturer (R&D Systems).
Knockdown of MyD88 by siRNA. MEFs plated in six-well plates were transfected with 50 pmol MyD88-specific siRNA (sc-35987; Santa Cruz) or control siRNA specific for lamin A and lamin C (5¢-GGUGGUGACGAU CUGGGCU-3¢; Dharmacon) with Lipofectamine 2000 (Invitrogen). After 48 h, cells were treated and then analyzed by immunoblot.
